Severe aortic stenosis (AS) — chronic / assessment for intervention
Valvular heart disease · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Calcific (elderly) or bicuspid/rheumatic narrowing of the aortic valve causing LV pressure overload. The classic triad of exertional syncope, angina and dyspnoea marks a sharp fall in survival. Definitive treatment is valve replacement (SAVR or TAVI) — medical therapy does not change the natural history.
Red flags
- Exertional syncope or presyncope
- Angina at rest or crescendo
- Acute pulmonary oedema / decompensation (critical AS)
- Falling LVEF or LV dilatation
- Hypotension after nitrate/vasodilator or sedation
- New AF with haemodynamic deterioration
Assessment
Differential diagnosis
- Hypertrophic obstructive cardiomyopathy (dynamic LVOT obstruction)
- Supravalvular/subvalvular AS
- Aortic sclerosis without significant gradient
- Mixed aortic valve disease
- HFpEF / other causes of exertional dyspnoea
- Coronary disease causing angina
Investigations
- Echocardiogram — peak velocity >=4 m/s, mean gradient >=40 mmHg, valve area <=1.0 cm2 (severe); assess LVEF, LVH, other valves
- Low-flow low-gradient AS: dobutamine stress echo (to distinguish true-severe from pseudo-severe) and/or CT aortic valve calcium score
- ECG (LVH, conduction disease), CXR
- BNP/NT-proBNP (prognostic, rising = decompensation)
- Coronary angiography / CT coronary before intervention
- CT aortogram for TAVI planning (annulus, access)
Management
- Grade severity on echo; if low-flow/low-gradient, confirm with dobutamine stress echo or calcium scoring
- Identify symptoms (angina, syncope, dyspnoea) and LV dysfunction — the triggers for intervention
- Avoid aggressive preload/afterload reduction: nitrates, high-dose ACEi/diuretics and vasodilators can cause catastrophic hypotension in severe AS
- Control AF rate and maintain sinus rhythm — atrial kick is critical for filling the stiff LV
- Refer promptly to Heart Team for SAVR vs TAVI once symptomatic, or asymptomatic with LVEF <50%, very severe AS, or abnormal exercise test
- Treat concomitant CAD and comorbidities before/at intervention
- Manage decompensated/critical AS cautiously — cardiology input, careful fluids, consider balloon valvuloplasty as bridge
Drugs & doses
No disease-modifying medical therapy — statins do NOT slow AS progression
Furosemide 20-40 mg PO/IV cautiously for pulmonary congestion (avoid over-diuresis/hypotension)
Beta-blocker (e.g. bisoprolol 1.25-2.5 mg PO once daily) for rate control of AF — cautious uptitration
Manage hypertension gently; ACEi/ARB may be used but start low and titrate slowly [verify, avoid hypotension]
Anticoagulation for AF per CHA2DS2-VASc (e.g. apixaban 5 mg PO BD)
AVOID GTN/nitrates and other vasodilators in critical symptomatic AS (risk of profound hypotension/arrest)
Disposition
Urgent cardiology/Heart Team referral once severe and symptomatic; admit decompensated or syncopal patients. Asymptomatic severe AS needs close surveillance echo (6-12 monthly) and exercise testing.
Complications & pitfalls
- Sudden cardiac death
- Heart failure / LV decompensation
- Atrial fibrillation
- Conduction block (esp. post-TAVI pacing need)
- Infective endocarditis
- Acquired von Willebrand / GI angiodysplasia bleeding (Heyde syndrome)
Exam pearls
- Onset of symptoms in severe AS signals average survival of only ~2-3 years without valve replacement — refer urgently.
- TAVI is now standard for most intermediate/high-risk and many lower-risk/older patients; SAVR favoured in younger, low-risk, bicuspid or when other cardiac surgery is needed (2021 ESC / 2020 AHA/ACC VHD guidance).
- Vasodilators and over-diuresis are dangerous — the hypertrophied LV is preload- and afterload-sensitive.
- Low-flow low-gradient severe AS (small valve area but low gradient due to poor LVEF or small stiff LV) is easily under-graded — use stress echo or calcium score.
- Heyde syndrome: unexplained GI bleeding + severe AS; valve replacement corrects the acquired vWF defect.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.